Related Experiment Video
Updated: Jun 14, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
[Effect of soy isoflavones on peri-menopausal symptom and estrogen]
Yanling Li1, Kemin Liu, Wen Lei
1Department of Nutrition, The first Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China. clala_008@sina.com
Objective:
To study the effect of soy isoflavones (SI) on improving peri-menopausal symptoms and the secretion of estrogen.
Methods:
Fifty women accompany with peri-menopausal symptoms were single-blindly randomized into two groups, the SI group with a daily 120 mg/d of soy isoflavones for eight weeks and the control group with placebos. Serum 17 beta-estrodiol (E2), follicle-stimulating hormone (FSH) and luteinizing hormone (LH), progesterone, testosterone and prolactin (PRL) were assessed at baseline and after 8 weeks of observation. The symptoms, such as the frequency of hot flash and sweating, insomnia and Kuppermann scores were observed.
Results:
By the end of the trial, BMI was significantly increased (P < 0.05). Hot flashes, Kuppermann scores and other index were significantly decreased (P < 0.01), and E2, progesterone and testosterone were significantly increased (P < 0.01 or P < 0.05). FSH was significantly decreased in SI group (P < 0.01). In comparison with control group, hot flash frequency, vaginal dryness, Kuppermann scores and other index were significantly decreased in SI group, E2, PRL and testosterone were also significantly increased in SI group and FSH, 2H were decreased.
Conclusion:
Menopausal symptoms and the secretion of estrogen were improved in peri-menopausal women on a daily dosage of 120 mg of soy isoflavones.
Related Concept Videos
Menopause
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Cancer Prevention
Some...
Hormonal Control of the Ovarian Cycle
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Hormonal Regulation
Hormonal Regulation
